The Osia System utilises humans’ natural ability to conduct sound through bone, helping you hear speech in difficult, noisy situations1 where people tell us they struggle the most.
Its innovative technology is designed to work in and with the body, so you can get the most out of hearing every day.
Learn more about the Osia System and how to get the most from your hearing.
Osia® 2 Sound Processor
The slim Osia® 2 Sound Processor is discreet, lightweight, and sits off the ear. Simply place it on your head, and you are ready to go.
The Osia System features a powerful implant that sits entirely under the skin. The active implant includes the Piezo Power™ transducer, which generates sound vibrations.
* Cochlear Baha 5 sound processors are compatible with iPhone, iPad and iPod touch. For compatibility information visit www.cochlear.com/compatibility.
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.
- Mylanus EAM, Hua H, Wigren S, et al. Multicenter Clinical Investigation of a New Active Osseointegrated Steady-State Implant System. Otol Neurotol. 2020;41(9):1249-1257.